Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Seehawer

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The American Journal of Pathology|August 5, 2024
Cell Death and Survival Mechanisms in CholangiocarcinogenesisLuana D'Artista, Marco Seehawer
Trends in Cell Biology|March 15, 2025
Epigenetic drivers of metalloproteinases and metastasisMarco Seehawer, Kornelia Polyak
Cancer Cell|June 12, 2019
The Worst from Both Worlds: cHCC-ICCMarco Seehawer, Luana D'Artista, Lars Zender
Nature Cell Biology|August 8, 2022
Untangling the web of intratumour heterogeneityZheqi Li, Marco Seehawer, Kornelia Polyak
Nature Reviews. Cancer|July 30, 2021
The immunological and metabolic landscape in primary and metastatic liver cancerXin Li, Pierluigi Ramadori, Dominik Pfister, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2026
Evaluation of targeted and immune combination therapies in a rat model of hormone receptor-positive breast cancerErnesto Rojas-Jimenez, Triet M Bui, Pengze Yan, et al.
Cancer Cell|October 4, 2024
Midkine as a driver of age-related changes and increase in mammary tumorigenesisPengze Yan, Ernesto Rojas Jimenez, Zheqi Li, et al.
Nature Cell Biology|June 26, 2024
Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3Marco Seehawer, Zheqi Li, Jun Nishida, et al.
Cancer Discovery|April 2, 2026
HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapiesMarie-Anne Goyette, Christopher Graser, Marco Seehawer, et al.
Journal of Hepatology|March 11, 2023
MYC determines lineage commitment in KRAS-driven primary liver cancer developmentLuana D'Artista, Athina Anastasia Moschopoulou, Iros Barozzi, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The American Journal of Pathology|August 5, 2024
Cell Death and Survival Mechanisms in CholangiocarcinogenesisLuana D'Artista, Marco Seehawer
Trends in Cell Biology|March 15, 2025
Epigenetic drivers of metalloproteinases and metastasisMarco Seehawer, Kornelia Polyak
Cancer Cell|June 12, 2019
The Worst from Both Worlds: cHCC-ICCMarco Seehawer, Luana D'Artista, Lars Zender
Nature Cell Biology|August 8, 2022
Untangling the web of intratumour heterogeneityZheqi Li, Marco Seehawer, Kornelia Polyak
Nature Reviews. Cancer|July 30, 2021
The immunological and metabolic landscape in primary and metastatic liver cancerXin Li, Pierluigi Ramadori, Dominik Pfister, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2026
Evaluation of targeted and immune combination therapies in a rat model of hormone receptor-positive breast cancerErnesto Rojas-Jimenez, Triet M Bui, Pengze Yan, et al.
Cancer Cell|October 4, 2024
Midkine as a driver of age-related changes and increase in mammary tumorigenesisPengze Yan, Ernesto Rojas Jimenez, Zheqi Li, et al.
Nature Cell Biology|June 26, 2024
Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3Marco Seehawer, Zheqi Li, Jun Nishida, et al.
Cancer Discovery|April 2, 2026
HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapiesMarie-Anne Goyette, Christopher Graser, Marco Seehawer, et al.
Journal of Hepatology|March 11, 2023
MYC determines lineage commitment in KRAS-driven primary liver cancer developmentLuana D'Artista, Athina Anastasia Moschopoulou, Iros Barozzi, et al.
Pageof 3